do not combine dpp-4 inhibitors with glp-1 receptor agonists guideline Frontiers DPP4 Inhibitor Mechanism of Action

These findings indicate that GLP-1RAs limit and stabilize the development of atherosclerotic plaques through anti-inflammatory mechanisms and by preventing vascular remodeling [62]

Interestingly, a 0.25 protective effect with a 0.95% CI of 0.160.39 was observed in patients undergoing EGD combined with colonoscopy [16]

doi: 10.1210/jc.2010-2081 [DOI] [PubMed] [Google Scholar] 89.Buse JB, Rosenstock J, Sesti G, et al

p = 0.05)

[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Ismail R, Cska I

Attention to the side effects of these drugs has focused on gastrointestinal symptoms, but bone health is an area where research is still early and conflicting